Geneva, June 16 -- International Clinical Trials Registry received information related to the study (ISRCTN21576805) titled 'Phase II trial: ETH47-201' on June 3.
Study Type: Interventional
Study Design:
Phase II double-blind randomized placebo-controlled study in 50 volunteers with asthma (Treatment)
Primary Sponsor: Ethris GmbH
Condition:
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended
Other
Intervention:
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months ...